Mensch und Maschine Software SE (FRA:MUM)

Market Cap	855.80M
Revenue (ttm)	270.74M
Net Income (ttm)	29.26M
Shares Out	n/a
EPS (ttm)	1.74
PE Ratio	29.25
Forward PE	23.10
Dividend	1.85 (3.61%)
Ex-Dividend Date	May 9, 2025

Volume	10,605
Average Volume	9,596
Open	51.20
Previous Close	50.80
Day's Range	50.90 - 51.50
52-Week Range	45.80 - 60.70
Beta	n/a
RSI	44.33
Earnings Date	Jul 23, 2025

About Revance Therapeutics

Mensch und Maschine Software SE provides computer aided design, manufacturing, and engineering, product data management, and building information modeling/management solutions in Germany, Austria, Switzerland, the United Kingdom, Italy, France, Hungary, and internationally. It operates in two segments, M+M Digitalization and M+M Software. The M+M Digitalization segment develops customized software solutions, resale of third-party software, and hardware, as well as related services. The M+M Software segment develops software for the CAD/CAM/CAE,...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 1984
• Employees: 1,179
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MUM

Financial Performance

In 2024, FRA:MUM's revenue was 325.84 million, an increase of 1.10% compared to the previous year's 322.31 million. Earnings were 30.49 million, an increase of 5.61%.